• 11:35 – 11:50 am: Welcome Address: “Let Us Build the Global SCM Community for the Bio-pharma Industry”

– Devendra Mishra, Co-founder and Executive Director, BSMA, and Adjunct Professor Supply Chain Management, Pepperdine University

– Franck Toussaint, Co-founder and Executive Director, BSMA Europe

– Ashok Srivastava, Co-Founder and Country Head, BSMA INDIA, and Former Vice President – Manufacturing, P&G

  • 11:50 – 12:30 pm: “Industry 360° – Building the Supply Chain as a Core Competency of the Bio-pharma Industry of India” – Panel Discussion

Senior SCM executives of the bio-pharma industry will address the challenges of internal enterprise integration for supply chain management, collaboration with trading partners, fostering a culture of quality assurance and risk management, compliance with governmental regulations, and adoption of enabling technologies. Solutions will be presented to address strategic sourcing, clinical trials management, contract research and manufacturing, temperature-controlled distribution, and human resource development. The initiatives discussed will seek integrity, quality, and risk mitigation in the supply chain for global competitiveness.

– Ravi Prakash Mathur, Global Head of Supply Chain, Dr Reddy’s Laboratories

– Lakshminarayana Neti, COO, Biological E

– Damodar Acharya, Former Director, Indian Institute of Technology, Kharagpur

– Bruno Lucidi, CEO, Agentus Therapeutics & Life Sciences Expert, Awex

– Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry

– Mahesh Bhalgat, COO, Shantha Sanofi

Moderator: Devendra Mishra, Co-Founder and Executive Director, BSMA

  • 12:30 – 1:00 pm: “Enabling innovation and Partnerships in Life Sciences to Improve Health for All”

An international R&D executive will focus on how the Bill & Melinda Gates Foundation is structured in terms of vision, key priorities and funding to address unmet global needs. Insights will be provided of the strategic endeavor of its Global Health division to leverage R&D for new products and make investments in Life Science Partnerships with government, public sectors, academia, and other institutions. The presentation will highlight the epidemiological transition being made by the Foundation from confronting communicable to non-communicable diseases.

– Dr. Harish Iyer, Senior Advisor, Scientific Programs, Bill and Melinda Gates Foundation India

  • 1:00 – 1:30 pm: Integrating Planning, Purchasing and Inventory Management for Optimal Patient Care in Life Sciences”

In the diverse business initiatives of plasma proteins, biosimilars, pharmaceuticals and CRO services, the formidable challenge of delivering patient care is being met by integrating demand planning with purchasing, manufacturing, distribution, and management of inventory in the end-to- end supply chain. The presentation will cover the people, processes, systems, and technologies which enable the realization of the patient care goal. Experience will be shared on how the organizational road blocks were successfully encountered and what the current initiatives are to achieve global competitiveness.

– Surendra Deodhar, Vice President and Head – Materials Management, Reliance Life Sciences

  • 1:30 – 2:30 pm: Networking Lunch
  • 2:30 – 3:15 pm: “Securing the Best-in-Class Ocean and Airfreight for Biologicals and Pharmaceuticals from India” – Panel Discussion

Services to optimize freight over ocean and air will be presented for biologicals and pharmaceuticals from India to global markets. Practical solutions will be offered to meet customer demands with economy in mind.

– Prasad Deshpande – Vice President – Supply Chain Management, Biocon

– Babettes Desfossez, Customs Attaché at Customs & Excise, Ministry of Finance, Belgium

– Alex Guillen, Former Global Cold Chain Director, Fisher Clinical Services

– Chakravarthi AVPS, CEO & Managing Director, Ecobliss

– Kiran Gubba, CEO, Gubba Cold Storage

– Moderator: Devdip Purkayastha, Adjunct Professor- Entrepreneurship, Indian Institute of Technology, Mumbai, & Former Vice President, Strategic Business Development, DHL

  • 3:15 – 3:45 pm: “Ensuring Product Quality and Integrity in the Emerging Cold Chain Network of Asia”

Presentation form an emerging global biopharmaceutical enterprise of India will highlight the logistics trends and a perspective for temperature-sensitive biomedicines for the next 5 -10 years in Asia, examine the key factors influencing Asia’s logistics networks, and discuss the strategies and means undertaken to mitigate risk in product delivery. Solutions will be discussed for overcoming the Achilles’s heel of Cold Chain while leveraging India’s cost advantage to deliver affordable healthcare solutions to patients, partners, and healthcare systems across the globe.

– Prasad Deshpande, Vice President & Head, Global Procurement, Supply Chain, and Contract Manufacturing, Biocon Limited

  • 3:45 – 4:15 pm: Networking Break
  • 4:15 – 4:35 pm: “Revolutionizing Bio-production: Cracking the Da Vinci Code!”

Insights will be provided of a game-changing innovation in significantly reduced-sized manufacturing facilities to enable the economic expansion of capacity with quality and reliability.

– Uday Ulhe, Business Solution Consultant, Finesse (Thermo Fisher Scientific)

– Benjamin Damien, Director of Business Operations, Univercells

  • 4:35 – 5:05 pm: “Personalized Medicine – Welcome to the Brave New World!” – Panel Discussion

The challenges of developing innovative products that harness a patient’s own immune system to target and kill cancer cells is a paradigm of cancer treatment for the 21st century. The supply chain for such products is personalized, rendering its design, development, and execution to be unprecedented. The establishment of processes for manufacturing and logistics, with real time controls, is a pioneering endeavor.

– Vishal Gandhi, CEO Biorx

– Franck Toussaint, Co-founder and Executive Director, BSMA Europe

– Abhinav Thakur, Managing Director, Accurex Biomedicals

– Bruno Lucidi, CEO, Argentus, Expert Life Sciences, Awex

– Moderator: Mahesh Bhalgat, COO, Shantha Sanofi

  • 5:05 – 5:15 pm: “Brexit – Trials and Tribulations for the Life Sciences Supply Chain Industry”

The current status of Brexit and its potential impact on trade with India will be comprehensively presented. Recognizing its impact on the overall supply chain, the consequential considerations of logistics hubs, manufacturing centers, potential HQ’s and even tax shelters will be discussed.

– Franck Toussaint, Executive Director, BSMA Europe, CEO, Biolog Europe

  • 5:15 – 5:45 pm: “Transportation, Qualification Strategy in Compliance with International Standards”

Temperature sensitive products should be shipped at the required temperature specifications and conditions. In order to meet these requirements Operational Qualification is a key element of the full package of qualification to demonstrate robustness of the system. An example of OQ for temperature truck will be shared.

– Eric Stener, Vice President, Global Supply Chain, Sanofi


Download the detailled program here: Program 2018